PROVECTUS BIOPHARMACEUTICALS, INC. ·
PVCT 8-K 2026-06-22
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) 8-K dated 2026-06-22 — accession 0001493152-26-029512. This URL is the filing, not the PVCT hub.
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) is a biotechnology company listed on OTCQB.
PROVECTUS BIOPHARMACEUTICALS, INC. filed a 8-K on 2026-06-22. Accession 0001493152-26-029512.
Cached items: 5.07. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.
Latest reported PVCT revenue for 2025-09-30 was $336.1K. Net income was -$1.3M. PVCT currently screens at market cap $25.9M.
Not investment advice. The PVCT SEC hub lists recent forms. The stock page is the research view.